Wilson Sonsini Advises Carbon Health on $100 Million Series D Investment Round
- Client Highlights
- Digital Health
- Life Sciences
On January 9, 2023, Carbon Health, a hybrid healthcare company that combines expert care with proprietary technology for easy everyday health, announced that it has received $100 million from CVS Health Ventures, CVS Health’s corporate venture capital platform, as part of an initial close of its Series D round. The funding enables the primary care provider to scale its Connective Care model into new geographies, sign new value-based care arrangements, and invest in technology as it aims to be a national leader in primary and urgent care. Wilson Sonsini Goodrich & Rosati advised Carbon Health on the transaction.
In addition to the investment, CVS Health will pilot the Carbon Health operating model inside select existing CVS Health locations, leveraging the Carbon Health model and software to help power the patient experience for CVS consumers.
The Wilson Sonsini team that advised Carbon Health on the transaction includes:
For more information, please see Carbon Health’s press release.